Janney Capital Management LLC Acquires 9,639 Shares of Quanterix Co. (NASDAQ:QTRX)

Janney Capital Management LLC boosted its holdings in Quanterix Co. (NASDAQ:QTRX) by 40.9% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 33,192 shares of the company’s stock after buying an additional 9,639 shares during the quarter. Janney Capital Management LLC owned approximately 0.09% of Quanterix worth $353,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. Hsbc Holdings PLC lifted its stake in shares of Quanterix by 34.7% in the 2nd quarter. Hsbc Holdings PLC now owns 12,738 shares of the company’s stock valued at $164,000 after acquiring an additional 3,279 shares during the last quarter. Emerald Mutual Fund Advisers Trust raised its position in Quanterix by 0.8% in the third quarter. Emerald Mutual Fund Advisers Trust now owns 563,247 shares of the company’s stock valued at $7,300,000 after purchasing an additional 4,406 shares during the last quarter. nVerses Capital LLC acquired a new stake in shares of Quanterix during the third quarter valued at about $60,000. American Century Companies Inc. increased its stake in shares of Quanterix by 14.5% in the second quarter. American Century Companies Inc. now owns 56,145 shares of the company’s stock valued at $742,000 after buying an additional 7,118 shares during the period. Finally, Peapack Gladstone Financial Corp bought a new position in Quanterix in the 3rd quarter valued at approximately $131,000. Institutional investors own 86.48% of the company’s stock.

Analyst Ratings Changes

Separately, TD Cowen boosted their target price on shares of Quanterix from $13.50 to $16.00 and gave the stock a “hold” rating in a report on Wednesday, November 13th.

Quanterix Trading Up 3.1 %

NASDAQ QTRX opened at $10.02 on Thursday. Quanterix Co. has a 12 month low of $8.21 and a 12 month high of $29.70. The business’s 50-day moving average price is $11.02 and its two-hundred day moving average price is $12.46.

Quanterix (NASDAQ:QTRX) last announced its earnings results on Monday, December 23rd. The company reported ($0.22) EPS for the quarter. Quanterix had a negative net margin of 30.12% and a negative return on equity of 11.74%. As a group, sell-side analysts anticipate that Quanterix Co. will post -0.94 earnings per share for the current year.

Quanterix Company Profile

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications.